sch-48973 has been researched along with Encephalitis, Polio in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copelyn, J | 1 |
| Hincks, JR | 2 |
| Wilmshurst, JM | 1 |
| Petersen, W | 1 |
| Howard, W | 1 |
| Jallow, S | 1 |
| Moonsamy, S | 1 |
| Seakamela, L | 1 |
| Suchard, M | 1 |
| Collett, MS | 2 |
| Eley, B | 1 |
| Sutter, RW | 1 |
| Modlin, JF | 2 |
| Zaffran, M | 1 |
| Benschop, K | 1 |
| Duizer, E | 1 |
| van der Avoort, H | 1 |
| Rhoden, E | 1 |
| Liu, H | 1 |
| Oberste, MS | 1 |
| McKinlay, MA | 1 |
| Hartford, M | 1 |
| Buontempo, PJ | 1 |
| Cox, S | 1 |
| Wright-Minogue, J | 1 |
| DeMartino, JL | 1 |
| Skelton, AM | 1 |
| Ferrari, E | 1 |
| Albin, R | 1 |
| Rozhon, EJ | 1 |
| Girijavallabhan, V | 1 |
| O'Connell, JF | 1 |
1 trial available for sch-48973 and Encephalitis, Polio
| Article | Year |
|---|---|
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.
Topics: Adult; Antiviral Agents; Cohort Studies; Female; Humans; Male; Middle Aged; Phenyl Ethers; Poliomyel | 2017 |
3 other studies available for sch-48973 and Encephalitis, Polio
| Article | Year |
|---|---|
Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir.
Topics: Agammaglobulinemia; Antiviral Agents; Drugs, Investigational; Feces; Genetic Diseases, X-Linked; Hum | 2020 |
Completing Polio Eradication: The Case for Antiviral Drugs.
Topics: Antiviral Agents; Humans; Phenyl Ethers; Poliomyelitis; Poliovirus Vaccine, Oral | 2017 |
SCH 48973: a potent, broad-spectrum, antienterovirus compound.
Topics: Animals; Antiviral Agents; Brain; Enterovirus; Enterovirus Infections; Halogenated Diphenyl Ethers; | 1997 |